Filter
712
Filtered Results: 712
Text search:
Stop
TB
Partnership
to
reach
Featured
Recommendations
64
New Publications
224
Language
Document type
No document type
521
Studies & Reports
79
Guidelines
50
Manuals
24
Strategic & Response Plan
23
Training Material
6
Fact sheets
5
Brochures
1
Situation Updates
1
Resource Platforms
1
Infographics
1
Countries / Regions
India
28
Global
23
Nepal
22
Kenya
22
Western and Central Europe
21
Rwanda
20
Uganda
19
Zambia
19
Bangladesh
18
South Africa
18
Tanzania
16
Liberia
16
Malawi
15
Myanmar / Burma
15
Eastern Europe
14
Sierra Leone
12
Asia
12
Ethiopia
12
Botswana
10
Nigeria
9
Cambodia
9
Namibia
9
Ghana
8
Latin America and the Carribbean
8
Philippines
7
South–East Asia Region
7
Lesotho
6
Indonesia
6
Zimbabwe
5
Mozambique
5
Africa
5
Timor Leste/ East Timor
4
Ukraine
4
Pakistan
4
Congo, Democratic Republic of
3
East and Southern Africa
3
Southern Africa
3
South Sudan
3
Tajikistan
2
Thailand
2
Albania
2
Burundi
2
Guinea
2
Germany
2
West and Central Africa
2
Vietnam
2
Brazil
2
Sri Lanka
2
Central African Republic
2
Bhutan
2
Somalia
2
Eswatini/ Swaziland
2
North Korea
1
Serbia
1
Benin
1
China
1
Syria
1
Laos
1
Senegal
1
Afghanistan
1
Peru
1
Bulgaria
1
Armenia
1
Venezuela
1
Middle East and North Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Maldives
1
Argentina
1
Papua New Guinea
1
Iraq
1
Authors & Publishers
Publication Years
Category
Countries
313
Clinical Guidelines
42
Public Health
33
Women & Child Health
15
Capacity Building
10
Key Resources
10
Pharmacy & Technologies
8
Toolboxes
TB
219
HIV
97
COVID-19
25
Health Financing Toolbox
15
NTDs
12
Polio
12
Caregiver
11
AMR
11
Disability
7
NCDs
7
Conflict
7
Rapid Response
6
Mental Health
6
Refugee
6
Ebola & Marburg
6
Pharmacy
6
Planetary Health
5
Global Health Education
5
Natural Hazards
3
Cholera
2
Ending the epidemics of HIV, tuberculosis and malaria by 2030 is within reach, but not yet fully in our grasp.
With only 11 years left, we have no time to waste. We must step up the fight now.
The WHO operational handbook on tuberculosis: tuberculosis preventive treatment is the companion, implementation guide to the 2020 WHO guidelines on TB preventive treatment.[1] Just as these guidelines are the first to be released under the rubric of the WHO consolidated TB guidelines, this handbook...
WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment
The 2020 recommendations for the programmatic management of TB preventive treatment are the first to be released under the rubric of WHO consolidated TB guidelines (Module 1 – Prevention). The WHO consolidated TB guidelines will gradually group all TB recommendations and will be complemented by ma...
The SAARC Member States have more than an estimated 2.0 million TB cases accounting for close to one-third of the total cases of TB in the world. India alone had almost one-fifth of the global disease burden due to TB. India, Pakistan and Bangladesh followed by Afghanistan are the major contributors...
Zoonotic tuberculosis (TB) is a form of TB in people predominantly caused by the bacterial species, Mycobacterium bovis, which belongs to the M. tuberculosis complex. The implications of zoonotic TB go beyond human health. The organism is host-adapted to cattle, where it is refer...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
THEME: TEENAGE PREGNANCY AN OBSTACLE TO MATERNAL HEALTH; LET US STOP IT NOW. 5th November 2013
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
This document aims to assist countries to take the first step towards better considering gender and equity issues in their efforts to tackle antimicrobial resistance (AMR), to inform the implementation of strategies in national action plans and contribute to improved reach and effectiveness of AMR e...
The Republic of the Union of Myanmar’s National Strategic Plan on HIV/AIDS 2016–2020 is the strategic guide for the country’s response to HIV at national, state/regional and local levels. The framework describes the current dynamics of the HIV epidemic and articulates a strategy to optimize in...
Myanmar is one of the world’s 22 high tuberculosis (TB) burden countries, and supporting TB control in Myanmar is a global priority. This report reflects the findings, discussions, conclusions and recommendations of the fourth international review mission of the Myanmar National TB Programme (NTP)...
Undernutrition increases the risk of tuberculosis (TB) and in turn TB can lead to malnutrition. Undernutrition is therefore highly prevalent among people with TB. It has been demonstrated that undernutrition is a risk factor for progression from TB infection to active TB disease and that undernutrit...
This is an update of a seven-year TB and Leprosy national strategic plan (TBL-NSP), which extends from 2013 to 2020. The update focuses on the plan covering from 2017-20 and is based on the 2017 external mid-term programme review key findings and recommendations; the global and national End TB strat...
This is a moment of reckoning in the fight against HIV, tuberculosis (TB) and malaria. For our Eighth Replenishment, the Global Fund needs US$18 billion to save 23 million lives, cut the death rate from the three diseases by 64% and help build a healthier, safer and more equitable world.
While many of the countries hit by the COVID-19 in the first few months of the year are now beginning to relax lockdown measures as infection and death rates fall, in the regions most affected by HIV, TB and malaria, such as Africa, South Asia and Latin America, the pandemic continues to accelerate....
This brief update on tuberculosis (TB) in the African region covers the state of TB in the WHO African region, strategic priorities and targets and the impact of COVID-19 on essential services. This is followed by key figures for the region, the role of WHO in country support and, recognizing the im...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h...
Global Tuberculosis Report 2021
recommended
Each year, the WHO Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
The...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, base...
The guide is suitable and can be used for the following audiences:
1. nurses and other trained healthcare workers who can use this manual as a self-study tool and then incorporate its guidance into their practice;
2. governmental and non-governmental employers of lay and professional TB treatment ...
